Observation on Therapeutic Effects of Recombinant Erythropoietin on Anemia in Patients with Renal Chronic Failure / 中国药房
China Pharmacy
; (12)2005.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-525318
Biblioteca responsável:
WPRO
ABSTRACT
OBJECTIVE:
To observe the effects and side effects of recombinant erytropoietin(rEPO)on patients with anemia in chronic renal failure(CRF).METHODS:
128 patients with anemia in CRF had been given rEPO by subcutaneous injection for12weeks,the clinical effects were observed by own control method.RESULTS:
Excellence cases amounted 91,efficacy cases33,and the overall efficacy rate was96.88%;The side effects included hypertension,coagulation in dialysis machine,pain in injection site and head,no severe adverse drug reactions were found;No degradation in renal function was found in non-dialysis patients during the medication.CONCLUSIONS:
rEPO could improve anemia in CRF safely and effectively.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
China Pharmacy
Ano de publicação:
2005
Tipo de documento:
Artigo